The adrenal gland is an important endocrine gland in the human body, and its function and importance in influencing human gender development are receiving more and more attention. When the adrenal glands fail to secrete hormones normally, a series of diseases may occur, one of which is congenital adrenal hyperplasia (CAH), especially CAH caused by 11β-hydroxylase deficiency. This condition leads to an abnormal increase in male hormones (such as testosterone) in the body, affecting the gender development of the embryo and child. This article will explore how 11β-hydroxylase deficiency affects gender and reveal its potential implications.
PathophysiologyClinical manifestations11β-hydroxylase deficiency leads to excessive production of androgens, primarily because the 11β-hydroxylase in the adrenal cortex is unable to synthesize cortisol. As a result, the adrenal glands overreact, leading to an overproduction of androgens.
Due to 11β-hydroxylase deficiency, patients often show different clinical symptoms. These include salt loss in early infancy and high blood pressure in early childhood and adulthood:
“Hypertension is often one of the most prominent clinical features of 11β-hydroxylase deficiency.”
However, not all patients will experience salt loss early on, depending on the adrenal glands' ability to produce aldosterone. As babies grow, many will develop high blood pressure, which is caused by continued stimulation of the adrenal cortex.
Because 11β-hydroxylase is not essential for the synthesis of sex hormones, its deficiency leads to excessive adrenal production of DHEA, androstenedione, and especially testosterone, which can affect the sex development of the embryo and child. Play a key role. This means:
"In severe cases, a genetically XX fetus may develop a distinctly male appearance."
Although the internal reproductive organs of these embryos develop normally as female, the external genitalia may show ambiguous male characteristics. XY fetuses usually do not show any abnormal characteristics.
The diagnosis of 11β-hydroxylase deficiency is generally confirmed by blood tests for significantly elevated levels of 11-deoxycortisol and 11-deoxycorticosterone, which are substrates for 11β-hydroxylase. Although similar to 21β-hydroxylase deficiency, hypertension in 11β-hydroxylase deficiency is often an important clue to the diagnosis.
The mainstay of treatment for this disease is lifelong glucocorticoid replacement therapy to maintain stable adrenal function and suppress excess hormone production. Salt loss that occurs in infancy can be alleviated by intravenous saline and high-dose hydrocortisone. In cases of hypertension, the use of glucocorticoids can effectively control the production of excess hormones.
As medical research on the adrenal gland continues to deepen, our understanding of the diseases caused by 11β-hydroxylase deficiency has become more comprehensive. But whether these physiological changes will affect the patient's gender identity and mental health is still a topic worth discussing?